bullish
China Feihe IPO (Part II): Right Formula for Growth
454 Views15 Oct 2019 05:32
China Feihe (FEIHE HK) , the largest domestic Infant Milk Formula (IMF) producer in China released its PHIP (Post Hearing Information Pack) on...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- China Feihe IPO Valuation: Reasonable Compared to Peers but Cheap Compared to Market Deal Multiples29 Oct 2019
- China Feihe IPO (Part II): Right Formula for Growth15 Oct 2019
- China Feihe IPO: Right Formula for Growth but There Could Be Risks12 Jul 2019
x